athenahealth Company Profile (NASDAQ:ATHN)

About athenahealth (NASDAQ:ATHN)

athenahealth logoathenahealth, Inc. provides network-based medical record, revenue cycle, patient engagement, care coordination and population health services. The Company also offers Epocrates and other point-of-care mobile applications. The Company delivers majority of its service offerings through a single instance of cloud-based software, athenaNet. The Company has a range of network-enabled services to support healthcare providers across the continuum of care. The Company offers various combinations of its services to its clients, including athenaOne and athenaOne for Hospitals and Health Systems, depending on whether they are medical groups and practices or hospitals and larger health systems. As of December 31, 2016, the Company connected care across a national network of approximately 88,000 providers and approximately 86 million patients. Its suite of network-enabled services includes athenaCollector, athenaClinicals, athenaCommunicator, athenaCoordinator, Population Health and Epocrates.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Healthcare Information Services
  • Sub-Industry: Health Care Technology
  • Symbol: NASDAQ:ATHN
  • CUSIP: 04685W10
  • Web:
  • Market Cap: $5.34 billion
  • Outstanding Shares: 39,834,000
Average Prices:
  • 50 Day Moving Avg: $114.85
  • 200 Day Moving Avg: $112.11
  • 52 Week Range: $90.11 - $142.40
  • Trailing P/E Ratio: 263.96
  • Foreward P/E Ratio: 55.64
  • P/E Growth: 3.53
Sales & Book Value:
  • Annual Revenue: $1.11 billion
  • Price / Sales: 4.81
  • Book Value: $17.27 per share
  • Price / Book: 7.76
  • EBIDTA: $112.4 million
  • Net Margins: 1.94%
  • Return on Equity: 6.41%
  • Return on Assets: 3.31%
  • Debt-to-Equity Ratio: 0.43%
  • Current Ratio: 1.73%
  • Quick Ratio: 1.73%
  • Average Volume: 651,280 shs.
  • Beta: 1.77
  • Short Ratio: 23.05

Frequently Asked Questions for athenahealth (NASDAQ:ATHN)

What is athenahealth's stock symbol?

athenahealth trades on the NASDAQ under the ticker symbol "ATHN."

How were athenahealth's earnings last quarter?

athenahealth, Inc (NASDAQ:ATHN) announced its earnings results on Thursday, April, 27th. The company reported $0.10 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.11 by $0.01. The business had revenue of $285.40 million for the quarter, compared to analysts' expectations of $296.49 million. athenahealth had a net margin of 1.94% and a return on equity of 6.41%. The company's revenue for the quarter was up 11.4% compared to the same quarter last year. During the same period in the prior year, the business earned $0.34 earnings per share. View athenahealth's Earnings History.

When will athenahealth make its next earnings announcement?

athenahealth is scheduled to release their next quarterly earnings announcement on Wednesday, July, 19th 2017. View Earnings Estimates for athenahealth.

Where is athenahealth's stock going? Where will athenahealth's stock price be in 2017?

21 equities research analysts have issued 12 month price objectives for athenahealth's stock. Their predictions range from $88.00 to $160.00. On average, they anticipate athenahealth's share price to reach $135.05 in the next twelve months. View Analyst Ratings for athenahealth.

What are analysts saying about athenahealth stock?

Here are some recent quotes from research analysts about athenahealth stock:

  • 1. Cantor Fitzgerald analysts commented, "We are maintaining our full-year revenue forecast of $439.6 million and EPS of $1.92, which are essentially at the high end of the guide of $440 million and $1.92. ELLI should remain a core holding for growth investors. Shares have been volatile over the last six months on rising interest rate risks. While ELLI has rebounded off the lows (+32% YTD), volatility could remain high this year, creating opportunities to add to positions on weakness. The formal Encompass NG release later this year could usher in a new era in 2018 as Ellie Mae expands beyond traditional mortgage processing into the broader lending market." (4/27/2017)
  • 2. Piper Jaffray Companies analysts commented, "We have updated our model and estimates to reflect the new company presentation. We have slightly lowered our PT to $160 from $162 to reflect our revised estimates. Despite this we remain confident in the company's FY17 outlook, and would be buying shares at current market valuation. Reiterate OW, PT $160." (2/7/2017)
  • 3. Stifel Nicolaus analysts commented, "ATHN reported 4Q EPS after the close 2/2/17 with a call at 8am ET this morning. Revenue ($288.2mn) was 5% ($17mn) below consensus and guidance, while EPS of $0.62 exceeded consensus ($0.51). Management reiterated 2017 revenue, bookings and adjusted operating income guidance; however, with the revenue miss revenue growth must reaccelerate more than previously expected and margins must improve less." (2/6/2017)
  • 4. According to Zacks Investment Research, "We believe that athenahealth’s strong product portfolio, expanding physician base and unique business model will continue to drive the top line. The recognition of athenahealth as an Electronic Health Record (EHR) usability leader is also a significant positive, in our opinion. However, the company's second quarter 2016 results disappointed us, as it missed the Zacks Consenus Estimates on both the lines. The company's guidance also failed to impress us. We believe lack of enterprise-sized deals, winding up of government funded stimulus and increasing competition in the HCIT market are major headwinds, at least in the near term." (8/4/2016)

Are investors shorting athenahealth?

athenahealth saw a decline in short interest in April. As of April 13th, there was short interest totalling 7,179,621 shares, a decline of 1.2% from the March 31st total of 7,263,997 shares. Based on an average daily volume of 309,442 shares, the short-interest ratio is currently 23.2 days.

Who are some of athenahealth's key competitors?

Who owns athenahealth stock?

athenahealth's stock is owned by a number of of retail and institutional investors. Top institutional investors include FMR LLC (0.00%), Janus Capital Management LLC (14.36%), Morgan Stanley (0.00%), Wellington Management Group LLP (0.00%), Vanguard Group Inc. (0.00%) and BlackRock Inc. (0.00%). Company insiders that own athenahealth stock include Amy Abernethy, Bradford Kyle Armbrester, Brandon H Hull, Daniel P Haley, David Eric Robinson, Ed Park, John A Kane, Jonathan Bush, Jonathan D Porter, Karl Stubelis, Kristi Ann Matus, Robert Cosinuke, Stephen N Kahane and Timothy John O'brien. View Institutional Ownership Trends for athenahealth.

Who sold athenahealth stock? Who is selling athenahealth stock?

athenahealth's stock was sold by a variety of institutional investors in the last quarter, including Point72 Asset Management L.P., TCW Group Inc., Eventide Asset Management LLC, Artisan Partners Limited Partnership, Kornitzer Capital Management Inc. KS, Clinton Group Inc., Janus Capital Management LLC and State of Wisconsin Investment Board. Company insiders that have sold athenahealth stock in the last year include Amy Abernethy, Bradford Kyle Armbrester, Brandon H Hull, Daniel P Haley, Ed Park, John A Kane, Jonathan Bush, Jonathan D Porter and Karl Stubelis. View Insider Buying and Selling for athenahealth.

Who bought athenahealth stock? Who is buying athenahealth stock?

athenahealth's stock was purchased by a variety of institutional investors in the last quarter, including BlackRock Inc., Morgan Stanley, Credit Suisse AG, Peregrine Capital Management LLC, Vanguard Group Inc., Royce & Associates LP, Sumitomo Mitsui Asset Management Company LTD and Canada Pension Plan Investment Board. View Insider Buying and Selling for athenahealth.

How do I buy athenahealth stock?

Shares of athenahealth can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of athenahealth stock cost?

One share of athenahealth stock can currently be purchased for approximately $134.09.

Analyst Ratings

Consensus Ratings for athenahealth (NASDAQ:ATHN) (?)
Ratings Breakdown: 1 Sell Rating, 8 Hold Ratings, 12 Buy Ratings
Consensus Rating:Buy (Score: 2.52)
Consensus Price Target: $135.05 (0.72% upside)

Analysts' Ratings History for athenahealth (NASDAQ:ATHN)
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
5/25/2017Robert W. BairdBoost Price TargetOutperform$140.00 -> $160.00LowView Rating Details
5/23/2017Dougherty & CoBoost Price TargetBuy -> Buy$123.00 -> $148.00LowView Rating Details
5/22/2017Oppenheimer Holdings Inc.Reiterated RatingOutperform$119.00 -> $154.00LowView Rating Details
5/19/2017Cantor FitzgeraldReiterated RatingOverweight$118.00 -> $140.00LowView Rating Details
5/19/2017Leerink SwannSet Price TargetHold$140.00LowView Rating Details
5/19/2017Evercore ISIReiterated RatingOutperform$118.00 -> $147.00LowView Rating Details
5/19/2017Jefferies Group LLCUpgradeUnderperform -> Hold$95.00 -> $135.00LowView Rating Details
5/1/2017Citigroup IncSet Price TargetBuy$128.00LowView Rating Details
5/1/2017Barclays PLCSet Price TargetUnderweight$97.00 -> $88.00MediumView Rating Details
4/4/2017Piper Jaffray CompaniesReiterated RatingOverweight$160.00LowView Rating Details
2/6/2017KeyCorpSet Price TargetBuy$140.00N/AView Rating Details
2/7/2017Berenberg BankInitiated CoverageBuy$143.00N/AView Rating Details
2/6/2017Stifel NicolausLower Price TargetHold$125.00 -> $116.00N/AView Rating Details
2/6/2017Canaccord GenuityReiterated RatingHold$112.00N/AView Rating Details
1/4/2017Pacific CrestUpgradeOverweight$140.00N/AView Rating Details
1/3/2017Royal Bank of CanadaInitiated CoverageOutperformN/AView Rating Details
1/3/2017Wells Fargo & CoInitiated CoverageOutperformN/AView Rating Details
10/28/2016JPMorgan Chase & Co.DowngradeOverweight -> Neutral$128.00 -> $111.00N/AView Rating Details
10/26/2016Morgan StanleyDowngradeOverweight -> Equal Weight$153.00 -> $117.00N/AView Rating Details
7/22/2016FBR & CoLower Price TargetMarket Perform$145.00 -> $140.00N/AView Rating Details
7/22/2016Deutsche Bank AGDowngradeBuy -> Hold$165.00 -> $147.00N/AView Rating Details
2/8/2016Goldman Sachs Group IncLower Price TargetNeutral$155.00 -> $149.00N/AView Rating Details
2/8/2016Topeka Capital MarketsUpgradeHold -> Buy$169.00 -> $160.00N/AView Rating Details
2/5/2016Cowen and CompanyReiterated RatingOutperform$174.00 -> $162.00N/AView Rating Details
10/23/2015Raymond James Financial, Inc.UpgradeMarket Perform -> Outperform$160.00N/AView Rating Details
10/21/2015Avondale PartnersInitiated CoverageMarket Perform$175.00N/AView Rating Details
6/18/2015StephensInitiated CoverageOutperform$168.00N/AView Rating Details
(Data available from 5/28/2015 forward)


Earnings History for athenahealth (NASDAQ:ATHN)
Earnings by Quarter for athenahealth (NASDAQ:ATHN)
Earnings History by Quarter for athenahealth (NASDAQ:ATHN)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
4/27/2017Q1 2017$0.11$0.10$296.49 million$285.40 millionViewN/AView Earnings Details
2/2/2017Q4 2016$0.51$0.62$303.72 million$288.20 millionViewListenView Earnings Details
10/20/2016Q3$0.47$0.60$280.17 million$276.67 millionViewListenView Earnings Details
7/21/2016Q2$0.42$0.34$274.07 million$261.90 millionViewListenView Earnings Details
4/28/2016Q1$0.26$0.34$248.49 million$256.15 millionViewListenView Earnings Details
2/4/2016Q415$0.41$0.45$257.68 million$257.50 millionViewN/AView Earnings Details
10/22/2015Q315$0.26$0.36$233.03 million$236.10 millionViewListenView Earnings Details
7/23/2015Q215$0.25$0.32$227.08 million$224.70 millionViewListenView Earnings Details
4/30/2015Q115($0.10)$0.24$205.24 million$206.40 millionViewListenView Earnings Details
2/5/2015Q414$0.39$0.58$207.99 million$213.20 millionViewN/AView Earnings Details
10/16/2014Q314$0.27$0.27$190.40 million$190.40 millionViewListenView Earnings Details
7/17/2014Q214$0.22$0.32$182.14 million$185.90 millionViewN/AView Earnings Details
4/17/2014Q114($0.01)$0.12$170.03 million$163.00 millionViewListenView Earnings Details
2/6/2014Q413$0.45$0.57$168.39 million$171.60 millionViewN/AView Earnings Details
10/17/2013Q313$0.31$0.29$154.80 million$151.50 millionViewN/AView Earnings Details
7/18/2013Q2 2013$0.22($0.08)$148.24 million$149.30 millionViewListenView Earnings Details
5/2/2013Q1 2013$0.23$0.38$121.05 million$125.60 millionViewListenView Earnings Details
2/7/2013Q4 2012$0.28$0.29$116.97 million$116.30 millionViewListenView Earnings Details
10/18/2012$0.26$0.30ViewN/AView Earnings Details
7/19/2012$0.23$0.24ViewN/AView Earnings Details
4/26/2012$0.17$0.17ViewN/AView Earnings Details
2/15/2012$0.23$0.26ViewN/AView Earnings Details
10/20/2011$0.20$0.24ViewN/AView Earnings Details
7/21/2011$0.19$0.22ViewN/AView Earnings Details
4/28/2011$0.13$0.17ViewN/AView Earnings Details
2/17/2011$0.20$0.28ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for athenahealth (NASDAQ:ATHN)
2017 EPS Consensus Estimate: $1.20
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20172$0.17$0.28$0.23
Q2 20172$0.06$0.34$0.20
Q3 20172$0.28$0.36$0.32
Q4 20172$0.41$0.50$0.46
(Data provided by Zacks Investment Research)


Dividend History for athenahealth (NASDAQ:ATHN)
No dividend announcements for this company have been tracked by

Insider Trades

Insider Trading and Institutional Ownership History for athenahealth (NASDAQ:ATHN)
Insider Ownership Percentage: 3.04%
Insider Trades by Quarter for athenahealth (NASDAQ:ATHN)
Institutional Ownership by Quarter for athenahealth (NASDAQ:ATHN)
Insider Trades by Quarter for athenahealth (NASDAQ:ATHN)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
5/18/2017Bradford Kyle ArmbresterSVPSell2,431$130.00$316,030.00View SEC Filing  
5/18/2017Brandon H. HullDirectorSell1,600$130.00$208,000.00View SEC Filing  
5/18/2017Jonathan BushCEOSell4,000$125.85$503,400.00View SEC Filing  
5/15/2017Jonathan D. PorterSVPSell300$109.48$32,844.00View SEC Filing  
4/25/2017Jonathan BushCEOSell8,000$120.00$960,000.00View SEC Filing  
1/27/2017John A KaneDirectorSell2,875$123.11$353,941.25View SEC Filing  
1/12/2017Jonathan BushCEOSell4,000$120.00$480,000.00View SEC Filing  
12/15/2016Amy AbernethyDirectorSell1,000$117.15$117,150.00View SEC Filing  
12/15/2016Ed ParkCOOSell2,500$117.15$292,875.00View SEC Filing  
12/15/2016Jonathan BushCEOSell8,000$120.00$960,000.00View SEC Filing  
12/1/2016Ed ParkCOOSell1,500$94.60$141,900.00View SEC Filing  
10/27/2016John A. KaneDirectorSell5,750$122.63$705,122.50View SEC Filing  
10/10/2016Bradford Kyle ArmbresterSVPSell2,545$130.00$330,850.00View SEC Filing  
10/10/2016Brandon H HullDirectorSell2,400$130.00$312,000.00View SEC Filing  
10/3/2016Daniel P HaleySVPSell2,109$124.43$262,422.87View SEC Filing  
10/3/2016Jonathan BushCEOSell4,000$124.34$497,360.00View SEC Filing  
9/7/2016Karl StubelisVPSell928$123.36$114,478.08View SEC Filing  
8/15/2016Ed ParkCOOSell4,000$124.20$496,800.00View SEC Filing  
8/1/2016Jonathan BushCEOSell4,000$128.19$512,760.00View SEC Filing  
7/27/2016John A KaneDirectorSell2,875$128.81$370,328.75View SEC Filing  
7/6/2016Ed ParkCOOSell1,500$136.85$205,275.00View SEC Filing  
7/1/2016Brandon H HullDirectorSell800$137.48$109,984.00View SEC Filing  
7/1/2016Jonathan BushCEOSell4,000$138.21$552,840.00View SEC Filing  
6/2/2016Brandon H HullDirectorSell800$130.00$104,000.00View SEC Filing  
6/1/2016Ed ParkCOOSell1,500$125.82$188,730.00View SEC Filing  
6/1/2016Jonathan BushCEOSell4,000$125.97$503,880.00View SEC Filing  
5/4/2016Ed ParkCOOSell1,500$127.81$191,715.00View SEC Filing  
5/2/2016Brandon H HullDirectorSell800$132.74$106,192.00View SEC Filing  
5/2/2016Jonathan BushCEOSell4,000$132.09$528,360.00View SEC Filing  
5/2/2016Kristi Ann MatusEVPSell415$133.27$55,307.05View SEC Filing  
4/25/2016Karl StubelisVPSell547$138.64$75,836.08View SEC Filing  
4/6/2016Ed ParkCOOSell1,500$139.15$208,725.00View SEC Filing  
4/1/2016Brandon H HullDirectorSell800$137.72$110,176.00View SEC Filing  
4/1/2016Jonathan BushCEOSell4,000$138.44$553,760.00View SEC Filing  
4/1/2016Kristi Ann MatusEVPSell415$138.61$57,523.15View SEC Filing  
3/3/2016Bradford Kyle ArmbresterSVPSell1,369$132.04$180,762.76View SEC Filing  
3/1/2016Brandon H HullDirectorSell1,600$130.00$208,000.00View SEC Filing  
3/1/2016Daniel P HaleySVPSell1,279$130.64$167,088.56View SEC Filing  
3/1/2016Ed ParkCOOSell1,500$131.66$197,490.00View SEC Filing  
3/1/2016Jonathan BushCEOSell4,000$129.61$518,440.00View SEC Filing  
3/1/2016Kristi Ann MatusEVPSell415$129.53$53,754.95View SEC Filing  
3/1/2016Timothy John O'brienCMOSell846$132.25$111,883.50View SEC Filing  
2/16/2016Bradford Kyle ArmbresterSVPSell1,657$127.11$210,621.27View SEC Filing  
2/16/2016Timothy John O'brienCMOSell816$127.08$103,697.28View SEC Filing  
2/3/2016Ed ParkCOOSell1,500$140.61$210,915.00View SEC Filing  
2/1/2016Jonathan BushCEOSell4,000$140.14$560,560.00View SEC Filing  
2/1/2016Kristi Ann MatusEVPSell415$141.08$58,548.20View SEC Filing  
1/27/2016John A. KaneDirectorSell2,875$140.81$404,828.75View SEC Filing  
1/6/2016Ed ParkCOOSell1,500$161.89$242,835.00View SEC Filing  
1/4/2016Jonathan BushCEOSell4,000$156.79$627,160.00View SEC Filing  
1/4/2016Kristi Ann MatusEVPSell415$159.06$66,009.90View SEC Filing  
12/2/2015Ed ParkCOOSell1,500$166.81$250,215.00View SEC Filing  
11/20/2015Stephen N KahaneEVPSell1,280$157.80$201,984.00View SEC Filing  
11/6/2015Stephen N KahaneEVPSell5,000$159.51$797,550.00View SEC Filing  
11/4/2015Ed ParkCOOSell1,500$162.32$243,480.00View SEC Filing  
11/3/2015Jonathan BushCEOSell14,750$156.50$2,308,375.00View SEC Filing  
10/27/2015John A. KaneDirectorSell2,875$150.44$432,515.00View SEC Filing  
10/23/2015Jonathan BushCEOSell20,000$157.50$3,150,000.00View SEC Filing  
10/23/2015Robert CosinukeCMOSell1,211$159.02$192,573.22View SEC Filing  
10/23/2015Stephen N KahaneEVPSell5,000$150.50$752,500.00View SEC Filing  
10/20/2015Stephen N KahaneEVPSell2,000$132.88$265,760.00View SEC Filing  
10/7/2015Ed ParkCOOSell1,500$134.23$201,345.00View SEC Filing  
10/2/2015Jonathan BushCEOSell1,000$130.74$130,740.00View SEC Filing  
9/15/2015Stephen N KahaneEVPSell2,000$135.77$271,540.00View SEC Filing  
9/2/2015Ed ParkCOOSell1,500$129.64$194,460.00View SEC Filing  
9/2/2015Jonathan BushCEOSell1,000$131.09$131,090.00View SEC Filing  
8/18/2015Stephen N KahaneEVPSell2,000$141.49$282,980.00View SEC Filing  
7/24/2015David Eric RobinsonDirectorSell10,000$130.00$1,300,000.00View SEC Filing  
7/21/2015Stephen N KahaneEVPSell2,000$117.32$234,640.00View SEC Filing  
7/2/2015Jonathan BushCEOSell1,000$114.17$114,170.00View SEC Filing  
6/2/2015Jonathan BushCEOSell1,000$115.32$115,320.00View SEC Filing  
4/27/2015John A KaneDirectorSell2,875$125.35$360,381.25View SEC Filing  
4/14/2015Karl StubelisVPSell1,115$126.28$140,802.20View SEC Filing  
4/2/2015Jonathan BushCEOSell1,000$118.77$118,770.00View SEC Filing  
3/10/2015James L MannDirectorSell13,106$121.27$1,589,364.62View SEC Filing  
3/3/2015Robert CosinukeCMOSell6,000$128.15$768,900.00View SEC Filing  
2/24/2015Jonathan BushCEOSell2,499$130.23$325,444.77View SEC Filing  
2/18/2015Jonathan BushCEOSell2,498$132.04$329,835.92View SEC Filing  
2/10/2015Jonathan BushCEOSell7,495$135.82$1,017,970.90View SEC Filing  
2/5/2015David Eric RobinsonDirectorSell25,000$143.17$3,579,250.00View SEC Filing  
2/3/2015Robert CosinukeCMOSell6,000$139.06$834,360.00View SEC Filing  
1/5/2015David Eric RobinsonDirectorSell25,000$145.14$3,628,500.00View SEC Filing  
1/5/2015Robert CosinukeCMOSell6,000$145.18$871,080.00View SEC Filing  
12/22/2014Robert CosinukeCMOSell6,000$139.32$835,920.00View SEC Filing  
12/2/2014Jonathan BushCEOSell1,000$116.55$116,550.00View SEC Filing  
10/10/2014Robert CosinukeCMOSell3,000$123.78$371,340.00View SEC Filing  
10/2/2014Jonathan BushCEOSell1,000$128.41$128,410.00View SEC Filing  
9/10/2014Robert CosinukeCMOSell6,000$138.08$828,480.00View SEC Filing  
8/11/2014Robert CosinukeCMOSell6,000$129.43$776,580.00View SEC Filing  
8/4/2014Jonathan BushCEOSell1,000$121.58$121,580.00View SEC Filing  
7/10/2014Robert CosinukeCMOSell6,000$120.10$720,600.00View SEC Filing  
7/2/2014Jonathan BushCEOSell1,000$129.45$129,450.00View SEC Filing  
7/1/2014Stephen N KahaneInsiderSell5,000$127.60$638,000.00View SEC Filing  
6/12/2014David Eric RobinsonDirectorSell30,000$124.12$3,723,600.00View SEC Filing  
6/10/2014Robert CosinukeCMOSell6,000$125.07$750,420.00View SEC Filing  
6/2/2014Jonathan BushCEOSell1,000$125.82$125,820.00View SEC Filing  
6/2/2014Stephen N KahaneInsiderSell5,000$126.42$632,100.00View SEC Filing  
5/2/2014Jonathan BushCEOSell1,000$123.21$123,210.00View SEC Filing  
5/1/2014Stephen KahaneInsiderSell5,000$121.96$609,800.00View SEC Filing  
4/16/2014Stephen KahaneInsiderSell10,000$143.96$1,439,600.00View SEC Filing  
4/14/2014David Eric RobinsonDirectorSell60,000$140.61$8,436,600.00View SEC Filing  
4/10/2014Robert CosinukeCMOSell6,000$151.14$906,840.00View SEC Filing  
4/2/2014Jonathan BushCEOSell1,000$161.74$161,740.00View SEC Filing  
3/10/2014Robert CosinukeCMOSell6,000$181.60$1,089,600.00View SEC Filing  
2/18/2014Timothy AdamsCFOSell30,000$194.58$5,837,400.00View SEC Filing  
2/12/2014Dev IttycheriaDirectorSell2,000$181.17$362,340.00View SEC Filing  
2/10/2014Robert CosinukeCMOSell6,000$172.72$1,036,320.00View SEC Filing  
2/3/2014Daniel OrensteinSVPSell1,000$146.73$146,730.00View SEC Filing  
2/3/2014David Eric RobinsonDirectorSell4,000$146.86$587,440.00View SEC Filing  
1/10/2014Robert CosinukeCMOSell6,000$132.92$797,520.00View SEC Filing  
1/3/2014David Eric RobinsonDirectorSell4,000$131.86$527,440.00View SEC Filing  
12/10/2013Robert CosinukeCMOSell6,000$132.77$796,620.00View SEC Filing  
12/3/2013David Eric RobinsonDirectorSell4,000$132.48$529,920.00View SEC Filing  
12/2/2013Jonathan BushCEOSell1,000$132.24$132,240.00View SEC Filing  
11/4/2013David Eric RobinsonDirectorSell4,000$137.26$549,040.00View SEC Filing  
11/4/2013Jonathan BushCEOSell1,000$137.26$137,260.00View SEC Filing  
11/1/2013Daniel H OrensteinSVPSell1,000$133.15$133,150.00View SEC Filing  
10/21/2013Timothy M AdamsCFOSell20,000$138.39$2,767,800.00View SEC Filing  
10/18/2013Ed ParkCOOSell10,021$123.36$1,236,190.56View SEC Filing  
10/18/2013Jonathan BushCEOSell20,000$120.00$2,400,000.00View SEC Filing  
10/10/2013Robert CosinukeCMOSell6,000$108.21$649,260.00View SEC Filing  
10/3/2013David Eric RobinsonDirectorSell4,000$111.01$444,040.00View SEC Filing  
10/2/2013Jonathan BushCEOSell1,000$110.16$110,160.00View SEC Filing  
9/10/2013Robert CosinukeCMOSell6,000$109.68$658,080.00View SEC Filing  
9/3/2013Daniel OrensteinSVPSell1,000$106.73$106,730.00View SEC Filing  
9/3/2013David Eric RobinsonDirectorSell4,000$106.53$426,120.00View SEC Filing  
9/3/2013Jonathan BushCEOSell22,105$106.45$2,353,077.25View SEC Filing  
8/19/2013John KaneDirectorSell2,000$111.23$222,460.00View SEC Filing  
8/15/2013John KaneDirectorSell5,000$110.03$550,150.00View SEC Filing  
8/12/2013Robert CosinukeCMOSell6,000$115.72$694,320.00View SEC Filing  
8/5/2013David Eric RobinsonDirectorSell4,000$114.01$456,040.00View SEC Filing  
8/1/2013Daniel H OrensteinSVPSell1,000$113.73$113,730.00View SEC Filing  
8/1/2013Jonathan BushCEOSell5,000$113.94$569,700.00View SEC Filing  
7/12/2013Timothy M AdamsCFOSell10,000$106.14$1,061,400.00View SEC Filing  
7/11/2013David Eric RobinsonDirectorSell4,000$90.00$360,000.00View SEC Filing  
7/10/2013Robert CosinukeCMOSell6,000$87.06$522,360.00View SEC Filing  
7/1/2013Daniel H OrensteinSVPSell1,000$85.01$85,010.00View SEC Filing  
7/1/2013Jonathan BushCEOSell5,000$85.39$426,950.00View SEC Filing  
6/17/2013David Eric RobinsonDirectorSell4,000$90.00$360,000.00View SEC Filing  
6/10/2013Robert CosinukeCMOSell6,000$85.74$514,440.00View SEC Filing  
6/3/2013Daniel H OrensteinSVPSell1,000$84.22$84,220.00View SEC Filing  
6/3/2013Jonathan BushCEOSell5,000$84.39$421,950.00View SEC Filing  
5/10/2013Robert CosinukeCMOSell6,000$84.80$508,800.00View SEC Filing  
5/1/2013Jonathan BushCEOSell5,000$95.70$478,500.00View SEC Filing  
2/26/2013David Eric RobinsonDirectorSell10,000$90.13$901,300.00View SEC Filing  
8/10/2012Robert CosinukeCMOSell3,000$92.35$277,050.00View SEC Filing  
(Data available from 1/1/2013 forward)


Headline Trends for athenahealth (NASDAQ:ATHN)
Latest Headlines for athenahealth (NASDAQ:ATHN)
DateHeadline logoDougherty & Co Raises athenahealth, Inc (ATHN) Price Target to $148.00 - May 28 at 12:32 AM logo[$$] Activist Elliott Management Weighs Athenahealth - May 27 at 2:03 AM logoRobert W. Baird Increases athenahealth, Inc (ATHN) Price Target to $160.00 - May 27 at 12:20 AM logoZacks: Analysts Anticipate athenahealth, Inc (ATHN) Will Post Quarterly Sales of $299.56 Million - May 26 at 5:40 PM logoZacks: Brokerages Expect athenahealth, Inc (ATHN) Will Post Quarterly Sales of $299.56 Million - May 26 at 5:18 PM logo$0.07 EPS Expected for athenahealth, Inc (ATHN) This Quarter - May 24 at 1:46 PM logoActivists Step Up Pressure on Internet Companies - May 23 at 9:30 AM logoInsider Selling: athenahealth, Inc (ATHN) Director Sells 1,600 Shares of Stock - May 22 at 7:48 PM logoInsider Selling: athenahealth, Inc (ATHN) CEO Sells 4,000 Shares of Stock - May 22 at 7:46 PM logoInsider Selling: athenahealth, Inc (ATHN) SVP Sells 2,431 Shares of Stock - May 22 at 7:46 PM logoOppenheimer Holdings Inc. Reaffirms "Outperform" Rating for athenahealth, Inc (ATHN) - May 22 at 5:40 PM logoathenahealth's (ATHN) Outperform Rating Reaffirmed at Evercore ISI - May 19 at 9:36 PM logoathenahealth, Inc (ATHN) Given a $140.00 Price Target by Leerink Swann Analysts - May 19 at 8:28 PM logoRobert W. Baird Reiterates $140.00 Price Target for athenahealth, Inc (ATHN) - May 19 at 7:16 PM logoAthenahealth Inc. (ATHN) Surged After Elliott Associates Disclosed Stake - May 19 at 3:39 PM logoAthenahealth shares soar after Elliott discloses 9.2 percent stake - May 19 at 3:39 PM logoATHN Crosses Above Average Analyst Target - May 19 at 3:39 PM logoAthenahealth and outspoken CEO Bush face activist with strong record of change - May 19 at 3:39 PM logoWall Street Weighs In on Athenahealth's Strategic Options - May 19 at 3:39 PM logoathenahealth, Inc (ATHN) Given Overweight Rating at Cantor Fitzgerald - May 19 at 2:52 PM
News IconPaul Singer's hedge fund just took a 9% stake in a health IT company — and the stock is jumping - May 19 at 10:22 AM logoathenahealth, Inc (ATHN) Upgraded by Jefferies Group LLC to "Hold" - May 19 at 7:20 AM logoAthenahealth Breaks Above 200-Day Moving Average - Bullish for ATHN - Nasdaq - May 18 at 3:39 PM logoElliott Calls Athenahealth Undervalued, Adds It to Tech Bids - May 18 at 3:39 PM logoSale or cost cuts at athenahealth 'possible' with new activist investor, says analyst - May 18 at 3:39 PM logoHere's What's Behind athenahealth, Inc.'s Meaningful Gain Today - May 18 at 3:39 PM logoAthenahealth Is Prime Deal Bait - May 18 at 3:39 PM logoHere's What's Behind athenahealth, Inc.'s Meaningful Gain Today - May 18 at 12:49 PM logoathenahealth Announces Meaningful Use Guarantee for Hospitals ... - GlobeNewswire (press release) - May 18 at 12:03 PM logoathenahealth’s More Disruption Please (MDP) Program Launches ‘MDP Labs’ to Accelerate Health Innovation & Entrepreneurs onto National Cloud Platform - May 18 at 12:03 PM logoSinger's Elliott Management Eyes 'Strategic Opportunities' at Athenahealth - May 18 at 12:03 PM logoActivist investor Paul Singer takes stake in Athenahealth, and shares surge - May 18 at 12:03 PM logoAthenahealth shares jump as Elliott takes stake - May 18 at 12:03 PM logoathenahealth Announces Meaningful Use Guarantee for Hospitals - May 17 at 12:15 PM logoJonathan D. Porter Sells 300 Shares of athenahealth, Inc (ATHN) Stock - May 16 at 10:17 PM logoBetter Buy: Veeva Systems Inc. vs. athenahealth - Motley Fool - May 16 at 8:47 PM logoBetter Buy: Veeva Systems Inc. vs. athenahealth - May 16 at 8:47 PM logoathenahealth, Inc. breached its 50 day moving average in a Bullish Manner : ATHN-US : May 16, 2017 - May 16 at 12:30 PM logoDespite preparation, Mass. hospitals still vulnerable to potential ransomware attack - May 16 at 12:30 PM logoathenahealth, Inc. to Present at the 45th Annual J.P. Morgan Global Technology, Media and Telecom Conference - May 15 at 9:29 AM logoathenahealth, Inc (ATHN) Receives Consensus Rating of "Hold" from Brokerages - May 9 at 9:25 AM logoHere's Why athenahealth, Inc. Fell 13% in April - May 8 at 3:37 PM logoHere's Why athenahealth, Inc. Fell 13% in April - May 8 at 1:43 PM logoathenahealth, Inc (ATHN) to Post Q2 2017 Earnings of $0.06 Per Share, SunTrust Banks Forecasts - May 8 at 8:21 AM logoathenahealth (ATHN) Earnings, Revenues Miss Estimates in Q1 - Yahoo Finance - May 5 at 1:48 AM logoathenahealth, Inc (ATHN) Sees Significant Drop in Short Interest - May 4 at 8:12 PM logoathenahealth (ATHN) Earnings, Revenues Miss Estimates in Q1 - May 4 at 3:45 PM logo$304.41 Million in Sales Expected for athenahealth, Inc (ATHN) This Quarter - May 3 at 3:16 PM logoathenahealth (ATHN) Earning Somewhat Favorable Press Coverage, Study Shows - May 2 at 7:32 PM logo10 Ways Lack of Communication Is Ruining Healthcare - May 2 at 3:45 PM



athenahealth (ATHN) Chart for Sunday, May, 28, 2017

This page was last updated on 5/28/2017 by Staff